Novartis Group

About Novartis Group

Novartis Group is a global healthcare company based in the UK, dedicated to reimagining medicine to improve and extend people’s lives. With a strong commitment to innovation, Novartis focuses on developing breakthrough treatments that address unmet medical needs.

The company operates through two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines division encompasses patented pharmaceuticals, including advanced therapies in areas such as oncology, cardiology, and immunology. Meanwhile, Sandoz specializes in generic pharmaceuticals and biosimilars, ensuring access to high-quality medicines for patients worldwide.

Novartis is driven by a vision to be a trusted leader in the healthcare industry, leveraging cutting-edge research and development to create transformative therapies. The company invests significantly in R&D, collaborating with various stakeholders, including academic institutions and biotech firms, to foster innovation.

In addition to its focus on drug development, Novartis is committed to sustainability and corporate responsibility. The company actively works to reduce its environmental footprint and enhance access to healthcare in underserved communities.

With a diverse workforce of over 100,000 employees globally, Novartis values inclusion and diversity, believing that a variety of perspectives drives better outcomes. The company’s headquarters in the UK serves as a hub for its operations, reflecting its dedication to advancing healthcare solutions.

Through its comprehensive portfolio and unwavering commitment to patient care, Novartis Group continues to make significant contributions to the global healthcare landscape.